NCT01934777View on ClinicalTrials.gov

Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

July 31, 2015

Conditions
Fatty LiverLiver FibrosisObesityMetabolic SyndromeNonalcoholic Fatty Liver Disease
Interventions
DRUG

Docosahexaenoic Acid plus Vitamin E plus choline

DHA 250 mg plus Vitamin E (39 UI) plus Choline 201 mg

DRUG

placebo pearls

placebo

Trial Locations (1)

00165

Bambino Gesù Hospital and Research Institute, Rome

All Listed Sponsors
lead

Bambino Gesù Hospital and Research Institute

OTHER

NCT01934777 - Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis | Biotech Hunter | Biotech Hunter